SABS icon

SAB Biotherapeutics

41 hedge funds and large institutions have $93.6M invested in SAB Biotherapeutics in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 5 closing their positions.

Holders
41
Holders Change
+4
Holders Change %
+10.81%
% of All Funds
0.72%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
9
Reduced
10
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Tudor Investment Corp
26
Tudor Investment Corp
Connecticut
$605K 60,000 +60,000 New
Goldman Sachs
27
Goldman Sachs
New York
$554K 55,000 -18,415 -25%
AWG
28
Alpha Wave Global
New York
$517K 51,330 +51,330 New
DWM
29
Dakota Wealth Management
Florida
$510K 50,575
CM
30
Crestline Management
Texas
$510K 50,611
Jane Street
31
Jane Street
New York
$360K 35,717 -312 -0.9%
EAM
32
Exos Asset Management
New York
$355K 35,264 +10,306 +41%
Citadel Advisors
33
Citadel Advisors
Florida
$321K 31,875 -6,421 -17%
LCM
34
Landscape Capital Management
New Jersey
$229K 22,721 +22,721 New
TCM
35
Tenor Capital Management
New York
$154K 15,271 +15,271 New
Walleye Trading
36
Walleye Trading
New York
$134K 13,303 -38,651 -74%
LP
37
LMR Partners
United Kingdom
$109K 10,849 +10,849 New
IFAM
38
Institutional & Family Asset Management
Colorado
$50K 5,000 +5,000 New
GCL
39
Glazer Capital LLC
New York
$13K 1,329 -531,175 -100%
Walleye Capital
40
Walleye Capital
New York
$201 19,953 -57,978 -74%
BFM
41
Boothbay Fund Management
New York
-400,000 Closed
WAM
42
Wolverine Asset Management
Illinois
-135,479 Closed
JPMorgan Chase & Co
43
JPMorgan Chase & Co
New York
-26,916 Closed
UBS Group
44
UBS Group
Switzerland
-1,483 Closed
TRCT
45
Tower Research Capital (TRC)
New York
-85 Closed
CFGS
46
Concourse Financial Group Securities
Alabama
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
$0 37 +27 +270%